Protein levels measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with Vemurafenib in combination with chromatin-targeting compounds (immunofluorescence dataset 3 of 4) - Dataset (ID:20276)
- Detail
- Small Molecules Studied
- Cell Lines Studied
- Proteins Studied
- Antibodies Studied
- Data Columns
- Results
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10282-2 | Vorinostat | suberoylanilide hydroxamic acid (SAHA); Zolinza | LSM-3828 |  | 5311 |
| 10068-1 | Vemurafenib | PLX4032; RG7204; R7204; RO5185426 | LSM-1068 |  | 42611257 |
| 10145-1 | Veliparib | ABT-888 | LSM-1146 |  | 11960529 |
| 10333-1 | UNC669 | LSM-6337 |  | 46931242 | |
| 10334-1 | UNC1215 | LSM-6338 |  | 57339144 | |
| 10320-1 | UNC0638 | LSM-6325 |  | 46224516 | |
| 10326-1 | Tranylcypromine | 2-PCPA | LSM-5578 |  | 19493 |
| 10316-1 | Selisistat | EX-527; SEN196 | LSM-6271 |  | 707029 |
| 10304-1 | Rucaparib | AG014699; PF-01367338 | LSM-4947 |  | 9931954 |
| 10315-1 | Rocilinostat | ACY-1215 | LSM-6324 |  | 53340666 |
| 10302-1 | RG-108 | LSM-6283 |  | 702558 | |
| 10318-1 | Resveratrol | LSM-42917 |  | 445154 | |
| 10313-1 | Pracinostat | SB939 | LSM-43290 |  | 56603532 |
| 10327-1 | PFI-1 | LSM-6331 |  | 71271629 | |
| 10144-2 | Olaparib | AZD2281; KU-0059436 | LSM-1145 |  | 23725625 |
| 10312-1 | Mocetinostat | MGCD0103 | LSM-5344 |  | 9865515 |
| 10325-1 | Methylstat | luo2011_cmpd2 | LSM-43292 |  | |
| 10314-1 | MC1568 | LSM-43291 |  | 71433510 | |
| 10305-1 | JW55 | LSM-6318 |  | 2946601 | |
| 10328-1 | (+)-JQ1 | (S)-JQ1 | LSM-6332 |  | 46907787 |
| 10329-1 | (-)-JQ1 | LSM-6333 |  | 49871818 | |
| 10332-1 | Ischemin | LSM-6336 |  | ||
| 10335-1 | IOX2 | LSM-6339 |  | 54685215 | |
| 10303-1 | Iniparib | BSI 201 | LSM-6317 |  | 9796068 |
| 10331-1 | I-BET151 | GSK1210151A | LSM-6335 |  | 52912189 |